Bioventus Inc. provided earnings guidance for the year 2024. For the year, the company expects net sales to be in the range of $520 million to $535 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.4 USD | -1.10% | +36.02% | +2.47% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.47% | 345M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
-5.53% | 5.33B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc. Provides Earnings Guidance for the Year 2024